Phosphoprotein enriched in astrocytes (PEA)-15 : A potential therapeutic target in multiple disease states
| dc.contributor.author | Greig, Fiona H | |
| dc.contributor.author | Nixon, Graeme F | |
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.contributor.institution | University of Aberdeen.Medical Sciences - Cardiovascular Group | en |
| dc.date.accessioned | 2014-12-15T13:41:01Z | |
| dc.date.available | 2014-12-15T13:41:01Z | |
| dc.date.issued | 2014-09 | |
| dc.description | Copyright © 2014 Elsevier Inc. All rights reserved. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 10 | |
| dc.format.extent | 623762 | |
| dc.identifier | 35634045 | |
| dc.identifier | c9542161-8b74-48c7-8710-554c583934a2 | |
| dc.identifier | 24657708 | |
| dc.identifier | 84905229949 | |
| dc.identifier.citation | Greig, F H & Nixon, G F 2014, 'Phosphoprotein enriched in astrocytes (PEA)-15 : A potential therapeutic target in multiple disease states', Pharmacology & Therapeutics, vol. 143, no. 3, pp. 265-274. https://doi.org/10.1016/j.pharmthera.2014.03.006 | en |
| dc.identifier.doi | 10.1016/j.pharmthera.2014.03.006 | |
| dc.identifier.iss | 3 | en |
| dc.identifier.issn | 0163-7258 | |
| dc.identifier.uri | http://hdl.handle.net/2164/4111 | |
| dc.identifier.vol | 143 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Pharmacology & Therapeutics | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | PEA-15 | en |
| dc.subject | ERK1/2 | en |
| dc.subject | proliferation | en |
| dc.subject | apoptosis | en |
| dc.subject | cancer | en |
| dc.subject | type 2 diabetes | en |
| dc.subject | RM Therapeutics. Pharmacology | en |
| dc.subject | Medical Research Council (MRC) | en |
| dc.subject | MR/K012789 | en |
| dc.subject.lcc | RM | en |
| dc.title | Phosphoprotein enriched in astrocytes (PEA)-15 : A potential therapeutic target in multiple disease states | en |
| dc.type | Journal article | en |